IGFBP3-mediated effects of an effective combination therapy on HCC

Abstract As all known, hepatocellular carcinoma (HCC) accounts for the majority of cases of liver cancer, which is the third leading cause of cancer mortality globally. Moreover, HCC is always accompanied with HBV infection. Here, we used CMAP, a systematic approach for the discovery of functional c...

Cijeli opis

Bibliografski detalji

Glavni autori:	Lin Chen, Lei Zhao, Guozhi Wu, Tiantian Zhang, Zhiwu Liu, David Fisher, Nguten Thi Thu Hien, Erkin Musabaev
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2025-08-01
Serija:	Scientific Reports
Teme:	HCC Quercetin IGFBP3 Resveratrol Combination therapy
Online pristup:	https://doi.org/10.1038/s41598-025-06148-w
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!